Join The Life Raft Group on November 9 at 12:00 PM for “Understanding Metabolic Changes in SDH-Deficient GIST” with Dr. Matthew Hemming of UMass Chan Medical School. This interactive, patient-focused webinar will explore what makes SDH-deficient GIST different and how changes in the way tumor cells produce and use energy may help them grow and survive. Dr. Hemming will share exciting new research on these tumors and possible new treatment approaches. Patients will have the opportunity to ask questions and engage directly with Dr. Hemming throughout the discussion.
These webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes.
About Our Presenter:
Dr. Matthew Hemming
UMass Chan Medical School
Matthew Hemming, MD, PhD, is an assistant professor of medicine at UMass Chan Medical School, practicing sarcoma medical oncologist, and principal investigator of the SarcomaLab. He received his BS from UC San Diego, PhD from Harvard University, and MD from Harvard Medical School. He completed internal medicine residency at Massachusetts General Hospital and Hematology/Oncology fellowship at Dana-Farber Cancer Institute. He has focused his clinical practice and laboratory work on sarcoma and GIST, with the goal to improve diagnostic and treatment strategies through basic and translational research.
